Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.24
0.06 (5.08%)
At close: Sep 04, 2025, 3:59 PM
1.23
-0.81%
Pre-market: Sep 05, 2025, 05:28 AM EDT
Telomir Pharmaceuticals Common Stock Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | -1.85 | -11.03 | -10.5 | -7.93 | -21.71 | -6.06 | -5.56 | -30.28 | -33.42 | -107.3 | -106.38 | -221.92 | -739.57 | -816.15 |
PEG Ratio | -0.01 | 0.44 | 0.21 | -0.03 | 0.28 | 0.22 | -0.01 | -2.94 | -0.15 | 88.52 | -0.98 | -0.97 | -51.77 | n/a |
PS Ratio | n/a | n/a | 6.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 77.95 | -596.71 | 189.26 | 430.01 | 80.28 | 50.26 | 60.28 | 95.16 | 53.29 | -221.14 | -221.14 | n/a | n/a | -1.5K |
P/FCF Ratio | -53.86 | -111.38 | -200.89 | -189.65 | -82.64 | -78.18 | -190.64 | -103.47 | -6.17K | -281.71 | -810.3 | -2.52K | -3.18M | -3.18M |
P/OCF Ratio | -53.86 | -111.38 | -200.89 | -189.65 | -82.64 | -78.18 | -190.64 | -103.47 | -6.17K | -281.71 | -810.3 | -2.52K | -3.18M | -3.18M |
OCF/S Ratio | n/a | n/a | -0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.58 | 0.15 | 0.21 | n/a | 0.00 | 0.03 | 0.61 | 0.13 | n/a | -0.62 | n/a | n/a | n/a |
Quick Ratio | 2.38 | 0.75 | 1.94 | 1.74 | 3.93 | 7.20 | 0.10 | 0.04 | 0.05 | n/a | 0.05 | n/a | n/a | n/a |
Current Ratio | 2.38 | 0.75 | 1.94 | 1.74 | 3.93 | 7.20 | 0.33 | 0.08 | 0.05 | n/a | 0.05 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | 14.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -3.78K | n/a | n/a | n/a | n/a | -0.44 | -11.24 | -1.26 | -11.5 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -10.54 | 13.53 | -4.51 | -13.55 | -0.92 | -2.07 | -2.71 | -0.79 | -0.4 | 0.52 | 0.52 | n/a | n/a | 0.46 |
Return on Assets | -6.11 | -4.44 | -2.19 | -5.75 | -0.69 | -1.79 | -1.95 | -0.32 | -0.26 | n/a | -10 | n/a | n/a | n/a |
Return on Invested Capital | -10.54 | 32.33 | -3.95 | -11.22 | -0.94 | -0.64 | -2.14 | -0.27 | -0.33 | n/a | 1.58 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |